Adeno-associated Virus (AAV) Vector-based Gene Therapy Market Size, Share & Trends Analysis Report by Disease Type (Hematological Malignancies, Neurological Disorders, Cardiovascular Diseases, Ophthalmic Diseases, Oncology) by Vector Serotype (AAV1, AAV2, AAV5, AAV6, AAV8, AAV9) by Administration Route (Intravenous, Intramuscular, Subcutaneous, Intraocular, Intracerebral) by End User (Hospitals, Research Institutes, Biopharmaceutical Companies) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2018 - 2023) & Forecast (2024 - 2032)

Billing Address

Choose Your Payment Method

Selected Plan

Standard License

$ 4299

Includes

  • Report accessible by 1 user only
  • Free 15% or 20 hours of customisation
  • Free post-sale service assistance
  • Direct access to lead analysts on mail
  • Report delivery on PDF & Excel
  • Report Coverage: Global
  • Free Post-Sale Service Assistance